End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.57 CNY | -1.08% | -3.82% | -26.74% |
09-06 | Gan & Lee Pharmaceuticals. announces an Equity Buyback for CNY 300 million worth of its shares. | CI |
09-05 | Gan & Lee Pharmaceuticals. authorizes a Buyback Plan. | CI |
Revenues ($) (Y-1) | Net margin (Y-1) | Operating Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Debt/EBITDA) (Y-1) | ||
---|---|---|---|---|---|---|---|
366M | +13.04% | +12.09% | +3.44% | +3.05% | -4.53x | ||
14.8B | +17.85% | +25.76% | +15.94% | +7.12% | 2.22x | ||
2.76B | +23.21% | +30.14% | +9.12% | +5.26% | -0.16x | ||
5.78B | +6.53% | +12.51% | +8.83% | +5.07% | 1.61x | ||
9.84B | +11.80% | +25.87% | +15.21% | +4.52% | 1.94x | ||
2.42B | +6.93% | +6.54% | +3.51% | +2.54% | 0.05x | ||
774M | +22.64% | +25.43% | +9.97% | +7.81% | -2.15x | ||
3.7B | +16.17% | +16.79% | +12.50% | +9.47% | -5.2x | ||
72.04M | -3.49% | -10.09% | -2.44% | -1.34% | 13.25x | ||
2.13B | +10.89% | +20.27% | +7.98% | +3.81% | 2.51x | ||
872M | -16.56% | -27.06% | -8.84% | -5.38% | 10.88x | ||
464M | -30.08% | -34.32% | -22.39% | -18.84% | 3.15x | ||
7.43B | +15.25% | +17.71% | +29.09% | +18.29% | -0.34x | ||
7.26B | +0.90% | +15.52% | +3.72% | +1.04% | 6.42x | ||
728M | +21.42% | +34.84% | +11.93% | +8.19% | - | ||
1.12B | +22.34% | +27.94% | +6.06% | +5.70% | - | ||
9.3M | -6,913.92% | -6,528.75% | - | -108.65% | -2.18x | ||
9.56M | -2,219.87% | -2,464.41% | - | - | - | ||
397M | -133.29% | -130.39% | -290.14% | -68.26% | 0.5x | ||
271M | -88.41% | -85.67% | -159.21% | - | 0.93x | ||
Average | 3.06B | -460.83% | -450.46% | -19.21% | -6.70% | 1.70x | |
Weighted average by Cap. | 6.75B | -128.42% | -120.23% | +3.60% | +2.07% | 1.73x |
- Stock Market
- Equities
- 603087 Stock
- Sector Gan & Lee Pharmaceuticals.
- Financial comparisons
MarketScreener is also available in this country: United States.
Switch edition